Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study

Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to dete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of psychiatry 2013-12, Vol.170 (12), p.1468-1476
Hauptverfasser: R. Girardin, François, Gex-Fabry, Marianne, Berney, Patricia, Shah, Dipen, Gaspoz, Jean-Michel, Dayer, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1476
container_issue 12
container_start_page 1468
container_title The American journal of psychiatry
container_volume 170
creator R. Girardin, François
Gex-Fabry, Marianne
Berney, Patricia
Shah, Dipen
Gaspoz, Jean-Michel
Dayer, Pierre
description Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.
doi_str_mv 10.1176/appi.ajp.2013.12060860
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1465864178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1465864178</sourcerecordid><originalsourceid>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpabZp_0IQlEIv3o4kS7J7C9s0XVhIwm4hORlZkhMtXtvRx2H762tnNwn00NMw8Mw7MzwInRGYEyLFNzUMbq62w5wCYXNCQUAh4A2aEc54Jikt3qIZANCs5Oz2BH0IYTu2wCR9j05ozkCwHGbozw-f7rNlZ5K2Bq_67h7fbLDr8LlJbcTXYa8fnIreabzsBhWd7WL4jjcPFvPsziqPF74PIVtbHV3fqRZfLC7xWntrOzeGXaWo-52dEl-y9ngdk9l_RO8a1Qb76VhP0e-fF5vFr2x1dblcnK8ylcsyZtQoUvMy56Wx0BghGwFSAqHcyroQUlAuDIe8sZyymlgJyhSc65ppJQqp2Sn6esgdfP-YbIjVzgVt21Z1tk-hIrnghciJLEb08z_otk9-_OqJKiVQwidKHCg9ve5tUw3e7ZTfVwSqyU412alGO9Vkp3q2Mw6eHeNTvbPmZexZxwh8OQIqaNU2XnXahVeuACqLnI0cO3BPi15v_P_6v7cPqMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469702158</pqid></control><display><type>article</type><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>EZB Electronic Journals Library</source><creator>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</creator><creatorcontrib>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</creatorcontrib><description>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.2013.12060860</identifier><identifier>PMID: 24306340</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Association</publisher><subject>Adolescent ; Adult ; Aged ; Antipsychotic Agents - adverse effects ; Biological and medical sciences ; Case-Control Studies ; Citalopram - adverse effects ; Cross-Sectional Studies ; Death, Sudden, Cardiac - epidemiology ; Electrocardiography ; Electrocardiography - drug effects ; Female ; General aspects ; Humans ; Inpatient care ; Inpatients - psychology ; Long QT Syndrome - chemically induced ; Long QT Syndrome - complications ; Long QT Syndrome - epidemiology ; Male ; Medical sciences ; Mental Disorders - complications ; Mental Disorders - drug therapy ; Mental health care ; Methadone - adverse effects ; Middle Aged ; Pharmacology ; Prevalence ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Risk Factors ; Side effects ; Switzerland - epidemiology ; Torsades de Pointes - chemically induced ; Torsades de Pointes - epidemiology</subject><ispartof>The American journal of psychiatry, 2013-12, Vol.170 (12), p.1468-1476</ispartof><rights>Copyright © 2013 by the American Psychiatric Association 2013</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 by the American Psychiatric Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</citedby><cites>FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/appi.ajp.2013.12060860$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.12060860$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2842,21605,21606,21607,27901,27902,77536,77541</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28027843$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24306340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>R. Girardin, François</creatorcontrib><creatorcontrib>Gex-Fabry, Marianne</creatorcontrib><creatorcontrib>Berney, Patricia</creatorcontrib><creatorcontrib>Shah, Dipen</creatorcontrib><creatorcontrib>Gaspoz, Jean-Michel</creatorcontrib><creatorcontrib>Dayer, Pierre</creatorcontrib><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Citalopram - adverse effects</subject><subject>Cross-Sectional Studies</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Electrocardiography</subject><subject>Electrocardiography - drug effects</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Inpatient care</subject><subject>Inpatients - psychology</subject><subject>Long QT Syndrome - chemically induced</subject><subject>Long QT Syndrome - complications</subject><subject>Long QT Syndrome - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Disorders - complications</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental health care</subject><subject>Methadone - adverse effects</subject><subject>Middle Aged</subject><subject>Pharmacology</subject><subject>Prevalence</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Risk Factors</subject><subject>Side effects</subject><subject>Switzerland - epidemiology</subject><subject>Torsades de Pointes - chemically induced</subject><subject>Torsades de Pointes - epidemiology</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpabZp_0IQlEIv3o4kS7J7C9s0XVhIwm4hORlZkhMtXtvRx2H762tnNwn00NMw8Mw7MzwInRGYEyLFNzUMbq62w5wCYXNCQUAh4A2aEc54Jikt3qIZANCs5Oz2BH0IYTu2wCR9j05ozkCwHGbozw-f7rNlZ5K2Bq_67h7fbLDr8LlJbcTXYa8fnIreabzsBhWd7WL4jjcPFvPsziqPF74PIVtbHV3fqRZfLC7xWntrOzeGXaWo-52dEl-y9ngdk9l_RO8a1Qb76VhP0e-fF5vFr2x1dblcnK8ylcsyZtQoUvMy56Wx0BghGwFSAqHcyroQUlAuDIe8sZyymlgJyhSc65ppJQqp2Sn6esgdfP-YbIjVzgVt21Z1tk-hIrnghciJLEb08z_otk9-_OqJKiVQwidKHCg9ve5tUw3e7ZTfVwSqyU412alGO9Vkp3q2Mw6eHeNTvbPmZexZxwh8OQIqaNU2XnXahVeuACqLnI0cO3BPi15v_P_6v7cPqMA</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>R. Girardin, François</creator><creator>Gex-Fabry, Marianne</creator><creator>Berney, Patricia</creator><creator>Shah, Dipen</creator><creator>Gaspoz, Jean-Michel</creator><creator>Dayer, Pierre</creator><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</title><author>R. Girardin, François ; Gex-Fabry, Marianne ; Berney, Patricia ; Shah, Dipen ; Gaspoz, Jean-Michel ; Dayer, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a479t-2da1b59459de0fd67f60770125e7b8676256d504fe523b1e70ad855cb3ca687c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Citalopram - adverse effects</topic><topic>Cross-Sectional Studies</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Electrocardiography</topic><topic>Electrocardiography - drug effects</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Inpatient care</topic><topic>Inpatients - psychology</topic><topic>Long QT Syndrome - chemically induced</topic><topic>Long QT Syndrome - complications</topic><topic>Long QT Syndrome - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Disorders - complications</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental health care</topic><topic>Methadone - adverse effects</topic><topic>Middle Aged</topic><topic>Pharmacology</topic><topic>Prevalence</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Risk Factors</topic><topic>Side effects</topic><topic>Switzerland - epidemiology</topic><topic>Torsades de Pointes - chemically induced</topic><topic>Torsades de Pointes - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>R. Girardin, François</creatorcontrib><creatorcontrib>Gex-Fabry, Marianne</creatorcontrib><creatorcontrib>Berney, Patricia</creatorcontrib><creatorcontrib>Shah, Dipen</creatorcontrib><creatorcontrib>Gaspoz, Jean-Michel</creatorcontrib><creatorcontrib>Dayer, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>R. Girardin, François</au><au>Gex-Fabry, Marianne</au><au>Berney, Patricia</au><au>Shah, Dipen</au><au>Gaspoz, Jean-Michel</au><au>Dayer, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>170</volume><issue>12</issue><spage>1468</spage><epage>1476</epage><pages>1468-1476</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases if a patient taking certain medications has hypokalemia, hepatitis C, HIV, or abnormal T wave morphology. ObjectiveThe authors aimed to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach.MethodAll ECG recordings over a 5-year period were reviewed for drug-induced long QT (heart-rate corrected QT ≥500 ms and certain or probable drug imputability) and associated conditions. Patients with drug-induced long QT (N=62) were compared with a sample of patients with normal ECG (N=143).ResultsAmong 6,790 inpatients, 27.3% had abnormal ECG, 1.6% had long QT, and 0.9% qualified as drug-induced long QT case subjects. Sudden cardiac death was recorded in five patients, and torsade de pointes was recorded in seven other patients. Relative to comparison subjects, patients with drug-induced long QT had significantly higher frequencies of hypokalemia, hepatitis C virus (HCV) infection, HIV infection, and abnormal T wave morphology. Haloperidol, sertindole, clotiapine, phenothiazines, fluoxetine, citalopram (including escitalopram), and methadone were significantly more frequent in patients with drug-induced long QT. After adjustment for hypokalemia, HCV infection, HIV infection, and abnormal T wave morphology, the effects of haloperidol, clotiapine, phenothiazines, and citalopram (including escitalopram) remained statistically significant. Receiver operating characteristic curve analysis based on the number of endorsed factors per patient indicated that 85.5% of drug-induced long QT patients had two or more factors, whereas 81.1% of patients with normal ECG had fewer than two factors.ConclusionsDrug-induced long QT and arrhythmia propensity substantially increase when specific psychotropic drugs are administered to patients with hypokalemia, abnormal T wave morphology, HCV infection, and HIV infection.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Association</pub><pmid>24306340</pmid><doi>10.1176/appi.ajp.2013.12060860</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-953X
ispartof The American journal of psychiatry, 2013-12, Vol.170 (12), p.1468-1476
issn 0002-953X
1535-7228
language eng
recordid cdi_proquest_miscellaneous_1465864178
source MEDLINE; American Psychiatric Publishing Journals (1997-Present); EZB Electronic Journals Library
subjects Adolescent
Adult
Aged
Antipsychotic Agents - adverse effects
Biological and medical sciences
Case-Control Studies
Citalopram - adverse effects
Cross-Sectional Studies
Death, Sudden, Cardiac - epidemiology
Electrocardiography
Electrocardiography - drug effects
Female
General aspects
Humans
Inpatient care
Inpatients - psychology
Long QT Syndrome - chemically induced
Long QT Syndrome - complications
Long QT Syndrome - epidemiology
Male
Medical sciences
Mental Disorders - complications
Mental Disorders - drug therapy
Mental health care
Methadone - adverse effects
Middle Aged
Pharmacology
Prevalence
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Risk Factors
Side effects
Switzerland - epidemiology
Torsades de Pointes - chemically induced
Torsades de Pointes - epidemiology
title Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-Induced%20Long%20QT%20in%20Adult%20Psychiatric%20Inpatients:%20The%205-Year%20Cross-Sectional%20ECG%20Screening%20Outcome%20in%20Psychiatry%20Study&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=R.%20Girardin,%20Fran%C3%A7ois&rft.date=2013-12-01&rft.volume=170&rft.issue=12&rft.spage=1468&rft.epage=1476&rft.pages=1468-1476&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/appi.ajp.2013.12060860&rft_dat=%3Cproquest_cross%3E1465864178%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1469702158&rft_id=info:pmid/24306340&rfr_iscdi=true